Related Experiment Video
Updated: Aug 5, 2026

13:00
Engineering Antiviral Agents via Surface Plasmon Resonance
Published on: June 14, 2022
Gold Nanoparticles for Antiviral Applications: Design Principles, Surface Engineering, and Mechanistic Insights
Kang Shu1, Yating Lei1, Linjie Li1
1School of Life and Health Sciences, Hunan University of Science and Technology, Xiangtan 411201, China.
Pharmaceutics
|July 28, 2026
Summary
Gold nanoparticles (AuNPs) offer tunable antiviral properties through precise engineering of their structure and surface chemistry. This review outlines design principles, synthesis, surface modification, and mechanisms for developing advanced AuNP-based antiviral nanotherapeutics.
Area of Science:
- Nanotechnology
- Materials Science
- Virology
Background:
- Gold nanoparticles (AuNPs) are adaptable nanoplatforms for antiviral applications due to tunable properties.
- Their size, morphology, plasmonic characteristics, and surface chemistry can be engineered for specific functions.
Purpose of the Study:
- To review the design principles of antiviral AuNPs from a structure-function-mechanism viewpoint.
- To provide a framework for developing next-generation AuNP-based antiviral nanotherapeutics.
Main Methods:
- Summarized synthetic routes (e.g., citrate reduction, seed-mediated growth, green synthesis) and interface-programming strategies.
- Discussed surface engineering approaches (e.g., PEGylation, nucleic acids, antibodies, peptides, glycans, drugs, biomimetic coatings).
- Examined AuNP inhibition of viral life cycle stages and immune modulation.
Main Results:
- Synthesis methods dictate AuNP size, morphology, and surface properties, influencing biofunctionalization.
- Surface ligand characteristics (density, orientation, stability) are critical for biological performance.
- Functionalized AuNPs can target various stages of viral replication, including entry, replication, assembly, and egress, and can be used for photothermal inactivation or vaccine delivery.
Conclusions:
- Rational design of AuNPs requires understanding structure-activity relationships and nano-bio interactions.
- Challenges include standardization, dynamic interactions, and translational barriers (safety, reproducibility, scale-up).
- This review offers a conceptual framework for advancing AuNP antiviral nanotherapeutics.

